Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?

被引:12
|
作者
Pinelli, Valentina [1 ]
Roca, Elisa [3 ]
Lucchini, Silvia [2 ]
Laroumagne, Sophie [3 ]
Loundou, Anderson [4 ]
Dutau, Herve [3 ]
Maldonado, Fabien [6 ]
Astoul, Philippe [3 ,5 ]
机构
[1] Hosp S Bartolomeo, Div Pneumol, Sarzana, Italy
[2] Spedali Civil Brescia, Div Nucl Med, I-25125 Brescia, Italy
[3] Hop Nord Marseille, Div Thorac Oncol Pleural Dis & Intervent Pulmonol, FR-13326 Marseille 20, France
[4] Aix Marseille Univ, Dept Publ Hlth & Biostat, Marseille, France
[5] Aix Marseille Univ, Fac Med, Marseille, France
[6] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
关键词
Pleural mesothelioma; F-18-fluorodeoxyglucose-positron emission tomography; Thoracoscopy; Malignant pleural effusions; RESPONSE EVALUATION; CANCER-THERAPY; PET; MANAGEMENT; THORACOSCOPY; INADEQUACY; RESECTION; SURVIVAL; CRITERIA; DISEASE;
D O I
10.1159/000381922
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Careful clinical staging in patients with malignant pleural mesothelioma (MPM) is fundamental in management planning. Positron emission tomography/computed tomography (PET/CT) is increasingly recognized as an important staging modality. Objectives: The purpose of this study was to assess whether the metabolic activity of the pleural tumor detected with PET/CT correlates with specific endoscopic features and pleural distribution of the lesions as assessed by medical thoracoscopy. Methods: Consecutive patients with MPM and available PET/CT performed before thoracoscopy were separated into 2 groups, according to their standardized uptake value (SUV). Kaplan-Meier-analysis for survival was performed on groups with low and high SUV. Agreement between PET/CT and thoracoscopy evaluation was analyzed using Cohen's kappa coefficient. The Wilcoxon test was used to compare the median SUV, and the. 2 test was used to evaluate differences in endoscopic findings. Results: A total of 32 patients were included. The median maximum SUV (SUV max) was 6.1 and patients were separated into 2 groups based on this cutoff. Patients with SUV max < 6.1 had a better survival than those with SUV max >= 6.1 (p = 0.005). The comparison between PET/CT and thoracoscopy showed a fair agreement for visceral and diaphragmatic pleural involvement and moderate agreement for the presence of nodular lesions. There was a statistically significant association between median SUV max and visceral pleural involvement; nodular lesions and visceral pleural involvement were more common in the high-SUV group than in the low-SUV group (p = 0.0012 and p = 0.03, respectively). Conclusions: PET/CT data may be predictive of thoracoscopic features of MPM associated with prognosis and staging, but the correlation is moderate at best. A degree of disagreement exists between these two modalities, which supports thoracoscopy as the gold standard for assessment of local invasion in MPM. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:558 / 564
页数:7
相关论文
共 50 条
  • [31] Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma
    Fortin, Marc
    Cabon, Emmanuelle
    Berbis, Julie
    Laroumagne, Sophie
    Guinde, Julien
    Elharrar, Xavier
    Dutau, Herve
    Astoul, Philippe
    [J]. RESPIRATION, 2020, 99 (01) : 28 - 34
  • [32] Integrated Positron Emission Tomography-Computed Tomography Does Not Accurately Stage Intrathoracic Disease of Patients Undergoing Trimodality Therapy for Malignant Pleural Mesothelioma
    Pilling, J.
    Dartnell, J. -A.
    Lang-Lazdunski, L.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (04): : 215 - 219
  • [33] COMPUTED-TOMOGRAPHY OF LOCALIZED PLEURAL MESOTHELIOMA
    DEDRICK, CG
    MCLOUD, TC
    SHEPARD, JAO
    SHIPLEY, RT
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 144 (02) : 275 - 280
  • [34] COMPUTED-TOMOGRAPHY OF INVASIVE PLEURAL MESOTHELIOMA
    SHIN, MS
    BAILEY, WC
    [J]. CT-JOURNAL OF COMPUTED TOMOGRAPHY, 1983, 7 (04): : 389 - 394
  • [35] Positron emission tomography/computed tomography: use for initial staging of malignant melanoma
    Harlan, Eric
    Davis, Mark D. P.
    Pittelkow, Mark R.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (09) : 1056 - 1058
  • [36] Talc pleurodesis mimics pleural metastases - Differentiation with positron emission tomography/computed tomography
    Weiss, N
    Solomon, SB
    [J]. CLINICAL NUCLEAR MEDICINE, 2003, 28 (10) : 811 - 814
  • [37] Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies - Assessment with positron emission tomography-computed tomography
    Toaff, JS
    Metser, U
    Goqfried, M
    Gur, O
    Deeb, ME
    Lievshitz, G
    Mercer, D
    Even-Sapir, E
    [J]. INVESTIGATIVE RADIOLOGY, 2005, 40 (04) : 204 - 209
  • [38] Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose
    Ceresoli, Giovanni L.
    Chiti, Arturo
    Zucali, Paolo A.
    Rodari, Marcello
    Lutman, Romano F.
    Salamina, Silvia
    Incarbone, Matteo
    Alloisio, Marco
    Santoro, Armando
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4587 - 4593
  • [39] Clinical evaluation of malignant pleural mesothelioma (MPM) with 18F-FDG positron emission tomography
    Nanni, C
    Fanti, S
    Melotti, B
    Pinto, C
    Farsad, M
    Moretti, A
    Castellucci, P
    Franchi, R
    Pettinato, C
    Marengo, M
    Boschi, S
    Martoni, A
    Monetti, N
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 399P - 399P
  • [40] Early response evaluation in malignant pleural mesothelioma by positron emission tomography with 18F-fluorodeoxyglucose
    Ceresoli, G. L.
    Chiti, A.
    Zucali, P. A.
    De Vincenzo, F.
    Rodari, M.
    Lutman, R. F.
    Salamina, S.
    Garassino, I.
    Campagnoli, E.
    Cavina, R.
    Santoro, A.
    [J]. LUNG CANCER, 2006, 54 : S19 - S20